Department of Neurosurgery, Kohnan Hospital, Taihaku-ku, Sendai, Japan.
Department of Neuroendovascular Therapy, Kohnan Hospital, Taihaku-ku, Sendai, Japan.
J Neurol Surg A Cent Eur Neurosurg. 2022 Mar;83(2):110-117. doi: 10.1055/s-0040-1721014. Epub 2021 Dec 12.
Modern imaging techniques can identify adverse factors for tumor removal such as cavernous sinus invasion before surgery, but surgeries for giant pituitary adenomas often reveal discrepancies between preoperative imaging and intraoperative findings because pituitary adenomas have feeding arteries with narrow diameters. Current imaging methods are not suitable for tumors with not only large vascular beds but also slow arterial filling.
This prospective study recruited 13 male subjects and 9 female subjects with giant pituitary adenomas between November 2011 and 2018. All the patients were investigated with three-dimensional magnetic resonance (MR) imaging, bone image computerized tomography (CT), and digital subtraction angiography (DSA) using a C-arm cone-beam CT scanner with a flat-panel detector and 50% diluted contrast medium. Fine angioarchitecture was evaluated and the tumor blush was quantified using newly developed region of interest (ROI) analysis to establish surgical strategies.
Seven patients demonstrated no or very faint tumor blushes. In these patients, feeding arteries run centripetally from the surface of the tumor. Fifteen patients showed significant tumor blushes, and the feeding arteries penetrated centrifugally from the inferoposterior pole to the upper pole of the tumor. All the patients were treated according to the angiographic information with successful hemostasis. The patients showed improvement and/or disappearance of the neurologic deficits. The faint and significant blush groups showed significant differences in intraoperative bleeding ( < 0.01) and operation time ( < 0.05).
Specialized evaluation focused on vascularization is required for successful therapy of giant pituitary adenomas.
现代成像技术可以在术前识别肿瘤切除的不利因素,如海绵窦侵犯,但由于垂体腺瘤有狭窄直径的供血动脉,因此对于巨大垂体腺瘤的手术,术前成像与术中发现往往存在差异。目前的成像方法不适合既有大血管床又有动脉缓慢充盈的肿瘤。
本前瞻性研究纳入了 2011 年 11 月至 2018 年间的 13 名男性和 9 名女性巨大垂体腺瘤患者。所有患者均接受三维磁共振(MR)成像、骨图像计算机断层扫描(CT)和数字减影血管造影(DSA)检查,使用带有平板探测器的 C 臂锥形束 CT 扫描仪和 50%稀释的造影剂。采用新开发的感兴趣区(ROI)分析评估精细血管结构,并对肿瘤染色进行定量,以制定手术策略。
7 例患者的肿瘤染色不明显或非常微弱。在这些患者中,供血动脉从肿瘤表面向中心运行。15 例患者表现出明显的肿瘤染色,供血动脉从肿瘤的后下极向中上极离心穿透。所有患者均根据血管造影信息进行治疗,成功止血。患者的神经功能缺损得到改善和/或消失。染色微弱和明显的两组患者在术中出血量(<0.01)和手术时间(<0.05)方面存在显著差异。
需要专门评估血管化情况,以成功治疗巨大垂体腺瘤。